Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
TerminatedNCT00658645
What is this study about?Researchers are comparing Bifeprunox, placebo and Quetiapine to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including RadnevoSchizophreniaMedication studyAges 18–65
- Countries
- Bulgaria, China, Greece, + 5 others
- Sponsor
- H. Lundbeck A/S
CompletedNCT04503954
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaPlacebo comparisonAges 20–99
- Countries
- Taiwan
- Sponsor
- National Taipei University of Nursing and Health Sciences
CompletedNCT00770744
What is this study about?Researchers compared Zicronapine and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including České BudějoviceSchizophreniaMedication studyAges 18–65
- Countries
- France, Czechia, China, + 5 others
- Sponsor
- H. Lundbeck A/S
TerminatedNCT03230864
What is this study about?This study evaluates the effectiveness of Lu AF35700 for people with schizophrenia.
This study ended early.
Multiple locations, including San DiegoSchizophreniaMedication studyAges 18+
- Countries
- United States, United Kingdom, Bulgaria, + 2 others
- Sponsor
- H. Lundbeck A/S
CompletedNCT03891186
Official study titleA Randomized Controlled Trial to Evaluate the Efficacy of Metacognitive Training for Schizophrenia Applied by Mental Health Nurses: Study Protocol
This study has finished and is no longer accepting participants.
In PortalegreSchizophreniaBehavioural studyAges 18–65
- Countries
- Portugal
- Sponsor
- University Rovira i Virgili
CompletedNCT02748486
Official study titleEfficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize... Among Patients of Psychiatric Rehabilitation Ward With Diagnosis of Schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaBehavioural studyAges 18+
- Countries
- Sponsor
- University of Warsaw
CompletedNCT01279070
Official study titleEfficacy of Repyflec Cognitive Remediation Group Training in Cognition, Functional Outcomes and Psychiatric Symptoms of Outpatients With Schizophrenia.
This study has finished and is no longer accepting participants.
In Sant Boi de LlobregatSchizophreniaBehavioural studyAges 18–60
- Countries
- Spain
- Sponsor
- Fundació Sant Joan de Déu
CompletedNCT00810667
What is this study about?Researchers compared Lu AE58054 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including LiègeSchizophreniaMedication studyAges 18–65
- Countries
- France, Belgium, Germany, + 5 others
- Sponsor
- H. Lundbeck A/S
CompletedNCT00654706
What is this study about?Researchers compared Sertindole and Quetiapine to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- H. Lundbeck A/S
CompletedNCT02110771
This study has finished and is no longer accepting participants.
In LyonSchizophreniaBehavioural studyAges 18–45
- Countries
- France
- Sponsor
- Hôpital le Vinatier
CompletedNCT01393613
What is this study about?Researchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
- Countries
- United States, Colombia, Croatia, + 5 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT00784238
Official study titleAn Open-label, Prospective, Non-Comparative Study to Evaluate Subjective Well-Being and Responses in Patients With Schizophrenia Who Had Switched to Paliperidone Extended-Release Tablets
This study has finished and is no longer accepting participants.
Multiple locations, including BusanSchizophreniaMedication studyAges 18–65
- Countries
- South Korea
- Sponsor
- Janssen Korea, Ltd., Korea